Description
A triazole derivative that serves as the active ingredient in a formulation that is used in adjunctive treatment of LGS to limit seizure frequency
Formal name: 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide
Synonyms: CGP 33101|RUF 331
Molecular weight: 238.2
CAS: 106308-44-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Neuroscience|Seizure Disorders